CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company
ProPhase Labs, Inc.
Sign in to watch- Ticker
- PRPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232577138
- Phone
- (215) 345-0919
- Business address
- 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
- Former names
- QUIGLEY CORP
- 4 Open-market buy 10% owner bought 48,596 shares at an average $1.40 ($68,034)
- 4 Open-market buy 10% owner bought 12,500 shares at an average $1.41 ($17,600)
- 4 Open-market buy 10% owner bought 121,940 shares at an average $1.45 ($177,386)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO & Chairman bought 500,000 shares at an average $1.56 ($780,191)
- 4 Grant or award CEO & Chairman acquired 50,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,745 shares (grant or award)
- 4 Grant or award Director acquired 2,745 shares (grant or award)
- 4 Grant or award Director acquired 2,745 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 6 of 11 · 215 filings